ArticleJournal of oral microbiology2026
Oral health and oral microbiota composition in patients with Parkinson's disease: a case‒control study.
Article in Journal of oral microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's disease (PD) is associated with motor and non-motor dysfunctions that may influence oral homeostasis. An altered microbiota has been linked to PD, yet oral microbial changes remain poorly characterized. This case‒control study aimed to determine if the oral microbiota, the oral health status, and salivary secretion differ between patients with PD and matched controls. Materials and methods: Forty participants (20 with PD and 20 controls) underwent standardized oral examinations, neurological scoring (Hoehn & Yahr; UPDRS II-III), and measurements of unstimulated (UWS) and stimulated whole saliva (SWS) flow rates. Microbial profiling of SWS samples and dorsal tongue scrapes was performed using long-read 16S rRNA gene sequencing (V1-V8). Alpha/beta diversity and differential abundance analyses were performed. Results: Patients with PD exhibited significantly lower UWS flow rates, higher plaque scores, and higher prevalence of xerostomia and drooling. Dental status and gingival inflammation did not differ between the groups. Microbial richness and Shannon diversity were lower in tongue scrapes from the PD group, but not in saliva samples. Conclusion: Patients with PD have lower UWS flow rates and a shift toward a more anaerobic, biofilm-adapted oral ecosystem, particularly on the tongue. The tongue microbiome may potentially serve as a sensitive biomarker of PD-related dysbiosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.